Graphic Design

Merck KGaA & EMD Serono

Biocytogen

 

The Betsy Lehman Center for Patient Safety

 

Infographics

 

Added Morsels

 

Selected Skylines of Merck KGaA & EMD Serono events

 

Merck, KGaA – Canadian ‘Plan of Action’ annual eventView additional skyline assets.

 

 

EMD Serono product launches & research milestones

 

EMD Serono’s North American 2019 FDA approval & launch of oncological treatment, Bavencio.View additional Bavencio Approval & Launch campaign assets.

 

 

Merck KGaA announces initiation of its pivotal Phase III program for Evobrutinib, used in relapsing multiple sclerosis. View additional Evobrutinib Phase III assets.

 

LINK TO EVOBRUTINIB BRAND BOOK

 

 

Assorted EMD Serono and Merck KGaA Brand Assets

 

 

 

EMD Serono’s Research & Development Pipeline Evolution

 

The R&D branch of EMD Serono’s life science and pharmaceutical announced it’s improved streamline process for maximizing team flexibility and navigating setbacks more efficiently.

 

 

 

 

Banner variations for Merck’s Global R&D landing page

 

Infographic: ‘Planet Transit‘


To detect planets outside our solar system, astronomers infer the presence of a planet by its ‘transit’ in front of its host star. In a ‘transit’, when the planet flies by, the star’s brightness diminishes, and sensitive telescopes can detect this occurrence..View additional infographic designs.